RWM
ABBV icon

RMG Wealth Management’s AbbVie ABBV Stock Holding History

RMG Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
1,001
+83
+9% +$17.9K 0.03% 65
2026
Q1 		$186K Buy
918
+496
+118% +$110K 0.02% 75
2025
Q4 		$91.8K Buy
422
+73
+21% +$16.6K 0.01% 109
2025
Q3 		$80.7K Sell
349
-56
-14% -$11.4K 0.01% 106
2025
Q2 		$76.9K Buy
+405
New +$75.3K 0.01% 102

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RMG Wealth Management's ABBV Position: Q2 2026 in Review

RMG Wealth Management increased its AbbVie (ABBV) stake by 9% in Q2 2026, buying an estimated $17.9K and bringing the position to 1,001 shares worth $249K. The position accounts for 0.03% of the portfolio, ranked #65.

RMG Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • RMG Wealth Management held 1,001 shares of AbbVie worth $249K as of Q2 2026.
  • RMG Wealth Management bought 83 AbbVie shares in Q2 2026, an estimated $17.9K.
  • AbbVie made up 0.03% of RMG Wealth Management's portfolio in Q2 2026, its #65 holding.
  • RMG Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RMG Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.